Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Bullboard Posts
Comment by canadapieton Aug 12, 2019 9:44am
114 Views
Post# 30017497

RE:RE:RE:RE:RE:Nasdaq Listing announcements

RE:RE:RE:RE:RE:Nasdaq Listing announcementspalinc2000 - (8/12/2019 9:24:17 AM) 
RE:RE:RE:RE:Nasdaq Listing announcements
Did you get any feedback from the company in response to your 10 questions?


Well, like you can see below i did ........And after i send him again my number...............a wonderful "silence" ! :-(

I had the same experience here in our beloved Belgium! A company with ticker MDXH (same space like EXAS in the US) . They were at 5 EUR then, now they sit at 1,20 EUR ........! And that in contrast with GLPG (mentioned it allready before), the CEO answering and intervening on the message board!!! (his words: " BOD/CEO's should have much more attention for the "little" shareholders, because the company needs those investors really hard from the beginning").



Mr Verbruggen,
I received your email yesterday and I would be pleased to talk to you on the phone.
If you send me you phone number and your availabilities I will call you as soon as I can.
Kind regards
 
 
 
 
Luc Tanguay, M.Sc., CFA 
Prsident et chef de la direction / 
President and Chief Executive Officer 


cid:image003.jpg@01D30474.60740510
Theratechnologies Inc. 
2015 Peel
Suite 1100
Montral, Qubec
CANADA H3A 1T8
 
Bullboard Posts